About Sangon Biotech
Sangon Biotech is a company based in Shanghai (China) founded in 2003.. Sangon Biotech has raised $300 million across 2 funding rounds from investors including CITIC Capital, Qiming Venture Partners and Greenwoods Investments. Sangon Biotech operates in a competitive market with competitors including Abcam, Stem Cell Technologies, GenScript, Sino Biological and Miltenyi Biotec, among others.
- Headquarter Shanghai, China
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$300 M (USD)
in 2 rounds
-
Latest Funding Round
$290 M (USD), Series B
Apr 20, 2023
-
Investors
CITIC Capital
& 7 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Sangon Biotech
Sangon Biotech has successfully raised a total of $300M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $290 million completed in April 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $290.0M
-
First Round
First Round
(03 Aug 2010)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2023 | Amount | Series B - Sangon Biotech | Valuation | Greenwoods Investments , Gl-investment | |
| Aug, 2010 | Amount | Series A - Sangon Biotech | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Sangon Biotech
Sangon Biotech has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include CITIC Capital, Qiming Venture Partners and Greenwoods Investments. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Acquisitions are targeted by CPE as a private equity firm.
|
Founded Year | Domain | Location | |
|
Private equity investment firm focused on multiple sectors
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Sangon Biotech
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Sangon Biotech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sangon Biotech Comparisons
Competitors of Sangon Biotech
Sangon Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Stem Cell Technologies, GenScript, Sino Biological and Miltenyi Biotec, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biological reagents and antibodies are developed for life science research.
|
|
| domain | founded_year | HQ Location |
Developer of cell culture media and ancillary reagents for life science research
|
|
| domain | founded_year | HQ Location |
Reagents and instruments are provided for life sciences research.
|
|
| domain | founded_year | HQ Location |
Reagents and kits are provided for clinical research applications.
|
|
| domain | founded_year | HQ Location |
Develops tools and products for research and clinical application
|
|
| domain | founded_year | HQ Location |
Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Sangon Biotech
Frequently Asked Questions about Sangon Biotech
When was Sangon Biotech founded?
Sangon Biotech was founded in 2003 and raised its 1st funding round 7 years after it was founded.
Where is Sangon Biotech located?
Sangon Biotech is headquartered in Shanghai, China.
Is Sangon Biotech a funded company?
Sangon Biotech is a funded company, having raised a total of $300M across 2 funding rounds to date. The company's 1st funding round was a Series A of $10M, raised on Aug 03, 2010.
What does Sangon Biotech do?
Sangon Biotech was founded in 2003 and is based in Shanghai, China. Operations focus on the biotechnology sector, where services such as oligonucleotide, gene, and peptide synthesis are delivered. DNA and next-generation sequencing, along with protein, antibody, and molecular biology services, are also offered. Reagents including PCR and enzymes, plus ELISA and PCR kits, are supplied to support research activities.
Who are the top competitors of Sangon Biotech?
Sangon Biotech's top competitors include Abcam, Sino Biological and Meridian Bioscience.
Who are Sangon Biotech's investors?
Sangon Biotech has 8 investors. Key investors include CITIC Capital, Qiming Venture Partners, Greenwoods Investments, CPE, and GL Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.